We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Pulsed Acoustic Device Hastens Tattoo Removal and Fading

By HospiMedica International staff writers
Posted on 04 Apr 2019
An innovative laser ancillary device use rapid pulsed acoustic shockwaves to accelerate the removal of unwanted tattoos.

The Soliton (Houston, TX, USA) Rapid Acoustic Pulse (RAP) device is designated as an accessory to a 1064 nm Q-Switched laser for black ink tattoo removal on the arms, legs, and torso in Fitzpatrick Skin Type I-III individuals. More...
RAP allows for multiple passes of a Q-Switched laser during a single treatment session; after the initial laser pass has been made and vacuoles have formed, the RAP Device is applied immediately afterward. Within seconds, the RAP’s acoustic waves remove the vacuoles, as well as further dispersing the ink pigment from the macrophages.

Another laser pass is now immediately possible and may be followed by another RAP pass, and so on. With the new approach, the RAP device enables multiple passes in a single treatment session, resulting in accelerated fading when compared to stand-alone laser treatment, and allowing tattoo removal to be completed in just two to three office visits. According to the company, RAP shockwave technology is also capable of inducing mechanical stress in fibroblasts, leads to new collagen growth, which could help reduce skin laxity and the appearance of cellulite.

“The human trials provided evidence of the potential for the RAP technology to accelerate tattoo fading,” said Chris Capelli, MD, President and CEO of Soliton. “The combination treatment of the RAP device and a laser outperformed a laser alone, showing an average of 80% fading after only two visits, versus 44% fading for the laser alone. After three Soliton multi-pass treatments, 100% of the treated tattoos had a complete (76-100% faded) response; in comparison, only 17% of the tattoos treated with the laser only had a complete response."

“Our strategy is a razor/razorblade model with consumable products for single-use applications, generating recurring revenue,” concluded Dr. Capelli. “We believe this business model will serve the company and our shareholders well as we enter into the tattoo removal segment, and eventually into additional aesthetics markets. We are excited about the prospects for expanding the use of our RAP technology to address new markets and other aesthetic issues.”

The current standard of care for tattoo removal is to use a Q-switched (pulsed) laser to ablate the tattoo ink particles into pieces small enough for the body's natural processes to remove them. Unfortunately, it is highly inefficient, requiring up to 10 or more office visits to achieve acceptable results.

Related Links:
Soliton


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Radiofrequency Generator
GX1
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.